CASDIN CAPITAL, LLC Denali Therapeutics Inc. Transaction History

CASDIN CAPITAL, LLC portfolio value:

$30.53M
portfolio value

CASDIN CAPITAL, LLC quarter portfolio value change:

+4.28%
quarter

Denali Therapeutics Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -33.67% -505K shares -13.60M $30.69 995K
Q2 2022 share 0.00% 0 shares -4.11M $29.43 1.5M
Q1 2022 share 0.00% 0 shares -18.64M $32.17 1.5M
Q4 2021 share Decrease -11.76% -200K shares -18.86M $45.05 1.5M
Q3 2021 share Increase +5.59% 90K shares -40.52M $50.45 1.7M
Q2 2021 share 0.00% 0 shares 34.35M $78.44 1.61M
Q1 2021 share Increase +22.90% 300K shares -17.79M $57.1 1.61M
Q4 2020 share 0.00% 0 shares 62.78M $83.76 1.31M
Q3 2020 share 0.00% 0 shares 15.26M $35.83 1.31M
Q2 2020 share Decrease -9.97% -145K shares 6.19M $24.18 1.31M
Q1 2020 share Increase +16.40% 205K shares 3.70M $17.51 1.45M
Q4 2019 share Increase +92.31% 600K shares 11.81M $17.42 1.25M
Q3 2019 share Increase +62.50% 250K shares 1.65M $15.32 650K
Q2 2019 share Increase +300.00% 300K shares 5.98M $20.76 400K
Q1 2019 share 0.00% 0 shares 256K $23.22 100K
Q4 2018 share Increase 0.00% 100K shares 2.06M $20.66 100K